Search Results 71-80 of 37864 for Two-phase
A Phase 2, Randomized Dose-ranging Study to Evaluate the Efficacy of Tralokinumab in Adults with Idiopathic Pulmonary Fibrosis · Overview · Participation ...
This is a multicenter, open-label, first-time-in-human study with a standard 3+3 dose-escalation phase in subjects with advanced solid tumors followed by an ...
The purpose of Phase II part 2 is to compare the Progression-Free Survival (PFS) of TG4001 in combination with avelumab vs avelumab alone in patients with ...
The first part of the study includes the first two phases of therapy: Induction and Consolidation. This part will collect information on the leukemia, as ...
The purpose of this two-part Phase 2 study is to assess the safety, tolerability and efficacy of aerosolized SF-RI 1 (AeroFact) when delivered via nCPAP at two ...
... Phase 2 dose (RP2D) and schedule of KTX-1001 for ... The first part of the study includes the first two phases of therapy: Induction and Consolidation.
This phase II multi-centered, randomized controlled trial of mechanical ventilation directed by esophageal pressure measurement will test the primary hypothesis ...
Patients will be enrolled in two stages: dose escalation stage (Stage I) ... phase 2 dose (RP2D) to be used in subsequent development of PRT3789. NOLA ...
Background: Sometimes the cancer advanced alveolar soft part sarcoma (ASPS) cannot be helped with surgery or other treatment. The drug atezolizumab unblocks the ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.